FDA NDC Directory · JSON-LD · Markdown

VITRAKVI

NDC 71777-392 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameLAROTRECTINIB
Labeler / ManufacturerLoxo Oncology, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211710
Dosage form / routeSOLUTION · ORAL
Active ingredientsLAROTRECTINIB (20 mg/mL)
Marketing started20181126
Package count1

External sources

Source: openFDA. Public-domain (CC0).